-
公开(公告)号:US20230150929A1
公开(公告)日:2023-05-18
申请号:US17912485
申请日:2021-03-17
IPC分类号: C07C311/51 , C07D215/20 , C07D215/22 , C07D239/78 , C07D217/04 , C07D487/04 , C07D213/74 , C07D209/04 , C07D231/56 , C07D213/61 , C07D231/12 , C07D307/38
CPC分类号: C07C311/51 , C07D209/04 , C07D213/61 , C07D213/74 , C07D215/20 , C07D215/22 , C07D217/04 , C07D231/12 , C07D231/56 , C07D239/78 , C07D307/38 , C07D487/04 , C07C2602/10
摘要: The invention relates generally to novel EPAC1 activators, such as Formula I and II and the preparation thereof as well as the use of EPAC1 activators disclosed herein as to selectively activate EPAC1 in cells.